ストックスクリーナーアプリを入手
92.11
1.43%
-1.34
アフターアワーズ：
92.12
0.01
+0.01%
前日終値:
$93.45
開ける：
$93.82
24時間の取引高:
300.40K
Relative Volume:
0.56
時価総額：
$907.13M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.06%
1か月 パフォーマンス:
+3.33%
6か月 パフォーマンス:
+14.74%
1年 パフォーマンス:
-1.78%
1日の値動き範囲:
$91.92
$93.82
1週間の範囲:
$91.92
$94.59
52週間の値動き範囲:
$77.67
$95.27
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
PPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
92.11 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
321.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
653.02 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
656.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
248.10 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
589.50 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf (PPH) 最新ニュース
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - The Globe and Mail
Pharmaceutical ETF on track for best week since 2020 - MarketWatch
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Big Pharma rebounds despite Trump’s latest tariff threat - Seeking Alpha
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio - Seeking Alpha
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - The Globe and Mail
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
PPH: Excellent Pharmaceutical ETF, But Bad Timing To Invest (NASDAQ:PPH) - Seeking Alpha
How Trump's Drug Pricing Policies Could Trigger An Epic Pharma Collapse - Seeking Alpha
Belpointe Asset Management LLC Takes $528,000 Position in VanEck Pharmaceutical ETF $PPH - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
Pharma stocks higher as Trump backs down from 250% tariff threat - Seeking Alpha
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - The Globe and Mail
LPL Financial LLC Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - The Globe and Mail
Markets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff Blitz - Money Morning
Envestnet Asset Management Inc. Reduces Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Cetera Investment Advisers Has $3.16 Million Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
J&J leads big pharma higher after earnings despite Trump’s latest tariff threat - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
ETFs To Gain On JNJ's Solid Q1 Earnings & Upbeat Outlook - Barchart.com
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - Seeking Alpha
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center (PPH) - Seeking Alpha
Janney Montgomery Scott LLC Cuts Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Innovative Industrial Properties (NYSE:IIPR) Rating Lowered to Peer Perform at Wolfe Research - Defense World
Vaneck Pharmaceutical Etf (PPH) 財務データ
Vaneck Pharmaceutical Etf (PPH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.71%
大文字化:
|
ボリューム (24 時間):